Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|October 6, 2018
20 years of experience with tumour necrosis factor inhibitors: what have we learned?Roberto Caporali, Gloria Crepaldi, Veronica Codullo, et al.
World Journal of Hepatology|April 8, 2015
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugsFrancesca De Nard, Monica Todoerti, Vittorio Grosso, et al.
Modern Rheumatology|September 8, 2017
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitorsSara Monti, Monica Todoerti, Veronica Codullo, et al.
Arthritis Research & Therapy|February 17, 2012
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugsSerena Bugatti, Antonio Manzo, Francesca Benaglio, et al.
Rheumatology (Oxford, England)|March 8, 2011
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonographyAntonio Manzo, Roberto Caporali, Barbara Vitolo, et al.
Arthritis Research & Therapy|October 25, 2016
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitorsAntonio Manzo, Francesca Benaglio, Barbara Vitolo, et al.
Rheumatology (Oxford, England)|October 6, 2018
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert ConsensusMonica Todoerti, Ennio Giulio Favalli, Florenzo Iannone, et al.
The Journal of Rheumatology|February 17, 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian StudyValentina Varisco, Mauro Viganò, Alberto Batticciotto, et al.
Autoimmunity Reviews|October 20, 2018
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian expertsEnnio Giulio Favalli, Andrea Becciolini, Roberto Caporali, et al.
Clinical and Experimental Rheumatology|August 29, 2013
Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet databaseCarlo A Scirè, Roberto Caporali, Piercarlo Sarzi-Puttini, et al.
Pageof 3